HomeCompareABBV vs LIN

ABBV vs LIN: Dividend Comparison 2026

ABBV yields 3.67% · LIN yields 4.00%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ABBV wins by $11.9K in total portfolio value
10 years
ABBV
AbbVie Inc.
● Live price
3.67%
Share price
$168.90
Annual div
$6.20
5Y div CAGR
8.9%
Payout ratio
58%
After 10 yrs · $10,000 · DRIP
Portfolio value
$39.9K
Annual income
$1,154.43
Full ABBV calculator →
LIN
LIN
● Live price
4.00%
Share price
$50.00
Annual div
$2.00
5Y div CAGR
5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$28.0K
Annual income
$899.19
Full LIN calculator →

Portfolio growth — ABBV vs LIN

📍 ABBV pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodABBVLIN
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ABBV + LIN cover 4 of 12 monthsgood coverage

Jan
ABBV
Feb
Mar
Apr
ABBV
May
Jun
Jul
ABBV
Aug
Sep
Oct
ABBV
Nov
Dec
ABBV pays
LIN pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ABBV
Annual income on $10K today (after 15% tax)
$312.02/yr
After 10yr DRIP, annual income (after tax)
$981.27/yr
LIN
Annual income on $10K today (after 15% tax)
$340.00/yr
After 10yr DRIP, annual income (after tax)
$764.31/yr
At 15% tax rate, ABBV beats the other by $216.95/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ABBV + LIN for your $10,000?

ABBV: 50%LIN: 50%
100% LIN50/50100% ABBV
Portfolio after 10yr
$34.0K
Annual income
$1,026.82/yr
Blended yield
3.02%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ABBV buys
0
LIN buys
0
No recent congressional trades found for ABBV or LIN in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricABBVLIN
Forward yield3.67%4.00%
Annual dividend / share$6.20$2.00
Payout ratio58%50%
1-year div growth4.7%5%
5-year div CAGR8.9%5%
Portfolio after 10y$39.9K$28.0K
Annual income after 10y$1,154.43$899.19
Total dividends collected$7.2K$6.4K
Payment frequencyquarterlyquarterly
SectorHealthcareMaterials

Year-by-year: ABBV vs LIN ($10,000, DRIP)

YearABBV PortfolioABBV Income/yrLIN PortfolioLIN Income/yrGap
1← crossover$11,520$399.75$11,120$420.00+$400.00ABBV
2$13,261$450.98$12,357$458.31+$904.00ABBV
3$15,255$508.41$13,721$499.76+$1.5KABBV
4$17,536$572.74$15,227$544.58+$2.3KABBV
5$20,145$644.78$16,885$593.02+$3.3KABBV
6$23,126$725.38$18,713$645.34+$4.4KABBV
7$26,532$815.52$20,724$701.81+$5.8KABBV
8$30,420$916.26$22,938$762.73+$7.5KABBV
9$34,855$1,028.80$25,372$828.41+$9.5KABBV
10$39,914$1,154.43$28,047$899.19+$11.9KABBV

ABBV vs LIN: Complete Analysis 2026

ABBVHealthcare

AbbVie is a pharmaceutical giant best known for Humira and newer blockbusters Skyrizi and Rinvoq. A Dividend Aristocrat with 52+ years of consecutive dividend increases. Strong free cash flow generation supports its above-average yield. The company's diversified pipeline reduces dependence on any single drug.

Full ABBV Calculator →

LINMaterials

LIN is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in LIN shares.

Full LIN Calculator →
📬

Get this ABBV vs LIN comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ABBV vs JNJABBV vs MRKABBV vs PFEABBV vs BMYABBV vs LLYABBV vs SCHDABBV vs JEPIABBV vs O

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.